Targeting BMI1 mitigates chemoresistance in ovarian cancer

• Anindya Dey,
• Shailendra Kumar Dhar Dwivedi,
• Lin Wang,
• Md Nazir Hossen,
• Fiifi Neizer-Ashun,
• Magdalena Bieniasz,
• Priyabrata Mukherjee,
• John D. Baird,
• Marla Weetall,
• Resham Bhattacharya

Affiliations

Anindya Dey

Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA

Shailendra Kumar Dhar Dwivedi

Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA

Lin Wang

Department of Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Md Nazir Hossen

Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove, CA 95757, USA

Fiifi Neizer-Ashun

Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA

Magdalena Bieniasz

Department of Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Priyabrata Mukherjee

Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA

John D. Baird

PTC Therapeutics, Inc, South Plainfield, NJ 07080, USA

Marla Weetall

PTC Therapeutics, Inc, South Plainfield, NJ 07080, USA

Resham Bhattacharya

Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA; Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA; Corresponding author. University of Oklahoma Health Science Center, 975 NE 10th Street, BRC-1409B Oklahoma City, OK 73104, USA. Fax: +405 271 2141